Protective effect of carboxymethyl-glucan (CM-G) against DNA damage in patients with advanced prostate cancer

Detalhes bibliográficos
Autor(a) principal: Magnani,Marciane
Data de Publicação: 2011
Outros Autores: Castro-Gomez,Raul Jorge Hernan, Mori,Mateus Prates, Kuasne,Hellen, Gregório,Emerson Pereira, Libos Jr,Farid, Cólus,Ilce Mara de Syllos
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Genetics and Molecular Biology
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1415-47572011000100023
Resumo: Carboxymethyl-glucan (CM-G) is a soluble derivative from Saccharomyces cerevisiae (1 → 3)(1 → 6)-β-D-glucan. The protective efficiency of CM-G against DNA damage in cells from patients with advanced prostate cancer (PCa), and undergoing Androgen Deprivation Therapy (ADT), was evaluated. DNA damage scores were obtained by the comet assay, both before and after treatment with CM-G. The reduction in DNA damage, ranging from 18% to 87%, with an average of 59%, was not related to the increased number of leukocytes in peripheral blood. The results demonstrate for the first time the protective effect of CM-G against DNA damage in patients with advanced PCa. Among smokers, three presented the highest reduction in DNA damage after treatment with CM-G. There was no observable relationship between DNA damage scores before and after treatment, and age, alcoholism and radiotherapy.
id SBG-1_268a9ece317ec8dfb0d600a4a715bceb
oai_identifier_str oai:scielo:S1415-47572011000100023
network_acronym_str SBG-1
network_name_str Genetics and Molecular Biology
repository_id_str
spelling Protective effect of carboxymethyl-glucan (CM-G) against DNA damage in patients with advanced prostate cancerantioxidantβ-D-glucancarboxymethyl-glucanprostate cancerCarboxymethyl-glucan (CM-G) is a soluble derivative from Saccharomyces cerevisiae (1 → 3)(1 → 6)-β-D-glucan. The protective efficiency of CM-G against DNA damage in cells from patients with advanced prostate cancer (PCa), and undergoing Androgen Deprivation Therapy (ADT), was evaluated. DNA damage scores were obtained by the comet assay, both before and after treatment with CM-G. The reduction in DNA damage, ranging from 18% to 87%, with an average of 59%, was not related to the increased number of leukocytes in peripheral blood. The results demonstrate for the first time the protective effect of CM-G against DNA damage in patients with advanced PCa. Among smokers, three presented the highest reduction in DNA damage after treatment with CM-G. There was no observable relationship between DNA damage scores before and after treatment, and age, alcoholism and radiotherapy.Sociedade Brasileira de Genética2011-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1415-47572011000100023Genetics and Molecular Biology v.34 n.1 2011reponame:Genetics and Molecular Biologyinstname:Sociedade Brasileira de Genética (SBG)instacron:SBG10.1590/S1415-47572010005000103info:eu-repo/semantics/openAccessMagnani,MarcianeCastro-Gomez,Raul Jorge HernanMori,Mateus PratesKuasne,HellenGregório,Emerson PereiraLibos Jr,FaridCólus,Ilce Mara de Sylloseng2011-01-28T00:00:00Zoai:scielo:S1415-47572011000100023Revistahttp://www.gmb.org.br/ONGhttps://old.scielo.br/oai/scielo-oai.php||editor@gmb.org.br1678-46851415-4757opendoar:2011-01-28T00:00Genetics and Molecular Biology - Sociedade Brasileira de Genética (SBG)false
dc.title.none.fl_str_mv Protective effect of carboxymethyl-glucan (CM-G) against DNA damage in patients with advanced prostate cancer
title Protective effect of carboxymethyl-glucan (CM-G) against DNA damage in patients with advanced prostate cancer
spellingShingle Protective effect of carboxymethyl-glucan (CM-G) against DNA damage in patients with advanced prostate cancer
Magnani,Marciane
antioxidant
β-D-glucan
carboxymethyl-glucan
prostate cancer
title_short Protective effect of carboxymethyl-glucan (CM-G) against DNA damage in patients with advanced prostate cancer
title_full Protective effect of carboxymethyl-glucan (CM-G) against DNA damage in patients with advanced prostate cancer
title_fullStr Protective effect of carboxymethyl-glucan (CM-G) against DNA damage in patients with advanced prostate cancer
title_full_unstemmed Protective effect of carboxymethyl-glucan (CM-G) against DNA damage in patients with advanced prostate cancer
title_sort Protective effect of carboxymethyl-glucan (CM-G) against DNA damage in patients with advanced prostate cancer
author Magnani,Marciane
author_facet Magnani,Marciane
Castro-Gomez,Raul Jorge Hernan
Mori,Mateus Prates
Kuasne,Hellen
Gregório,Emerson Pereira
Libos Jr,Farid
Cólus,Ilce Mara de Syllos
author_role author
author2 Castro-Gomez,Raul Jorge Hernan
Mori,Mateus Prates
Kuasne,Hellen
Gregório,Emerson Pereira
Libos Jr,Farid
Cólus,Ilce Mara de Syllos
author2_role author
author
author
author
author
author
dc.contributor.author.fl_str_mv Magnani,Marciane
Castro-Gomez,Raul Jorge Hernan
Mori,Mateus Prates
Kuasne,Hellen
Gregório,Emerson Pereira
Libos Jr,Farid
Cólus,Ilce Mara de Syllos
dc.subject.por.fl_str_mv antioxidant
β-D-glucan
carboxymethyl-glucan
prostate cancer
topic antioxidant
β-D-glucan
carboxymethyl-glucan
prostate cancer
description Carboxymethyl-glucan (CM-G) is a soluble derivative from Saccharomyces cerevisiae (1 → 3)(1 → 6)-β-D-glucan. The protective efficiency of CM-G against DNA damage in cells from patients with advanced prostate cancer (PCa), and undergoing Androgen Deprivation Therapy (ADT), was evaluated. DNA damage scores were obtained by the comet assay, both before and after treatment with CM-G. The reduction in DNA damage, ranging from 18% to 87%, with an average of 59%, was not related to the increased number of leukocytes in peripheral blood. The results demonstrate for the first time the protective effect of CM-G against DNA damage in patients with advanced PCa. Among smokers, three presented the highest reduction in DNA damage after treatment with CM-G. There was no observable relationship between DNA damage scores before and after treatment, and age, alcoholism and radiotherapy.
publishDate 2011
dc.date.none.fl_str_mv 2011-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1415-47572011000100023
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1415-47572011000100023
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/S1415-47572010005000103
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira de Genética
publisher.none.fl_str_mv Sociedade Brasileira de Genética
dc.source.none.fl_str_mv Genetics and Molecular Biology v.34 n.1 2011
reponame:Genetics and Molecular Biology
instname:Sociedade Brasileira de Genética (SBG)
instacron:SBG
instname_str Sociedade Brasileira de Genética (SBG)
instacron_str SBG
institution SBG
reponame_str Genetics and Molecular Biology
collection Genetics and Molecular Biology
repository.name.fl_str_mv Genetics and Molecular Biology - Sociedade Brasileira de Genética (SBG)
repository.mail.fl_str_mv ||editor@gmb.org.br
_version_ 1752122383686172672